Multiple endocrine neoplasia type 2

Multiple endocrine neoplasia type 2 Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple endocrine neoplasia type 2 from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria
History & Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Multiple endocrine neoplasia type 2 On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multiple endocrine neoplasia type 2
CDC on Multiple endocrine neoplasia type 2
Multiple endocrine neoplasia type 2 in the news
Blogs on Multiple endocrine neoplasia type 2
Directions to Hospitals Treating Multiple endocrine neoplasia type 2
Risk calculators and risk factors for Multiple endocrine neoplasia type 2

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Synonyms and keywords: Endocrine neoplasia multiple type 2; Familial endocrine adenomatosis type 2; Familial endocrine adenomatosis type 2a; Familial endocrine adenomatosis type 2b; Familial chromaffinomatosis type 2; Familial medullary thyroid carcinoma; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasia syndrome type 2; Multiple endocrine neoplasia syndrome type 2a; Multiple endocrine neoplasia syndrome type 2b; MEN type 2; MEN type 2a; MEN type 2b; MEN 2 syndrome; MEN 2 - Multiple endocrine neoplasia syndrome type 2; MEN type II; MEN type IIa; MEN type IIb; MEA type 2; MEA type 2a; MEA type 2b; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasms type 2; Multiple endocrine neoplasms type 2a; Multiple endocrine neoplasms type 2b; MEA 2; MEA 2a; MEA 2b; MEA II; MEA IIa; MEA IIb; MEN 2; MEN 2a; MEN 2b; MEN II; MEN IIa; MEN IIb; Multiple Endocrine Neoplasms Type 2; Multiple Endocrine Neoplasms Type 2a; Multiple Endocrine Neoplasms Type 2b; Multiple neuroma syndrome type 2; Multiple neuroma syndrome type 2a; Multiple neuroma syndrome type 2b; PTC syndrome; Sipple's syndrome; Pheochromocytoma and amyloid producing medullary thyroid carcinoma; Wagenmann-Froboese syndrome

Diagnosis

History & Symptoms | Physical Examination | Lab Tests | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

See also

• Multiple endocrine neoplasia
• Multiple endocrine neoplasia type 1